London – October 06, 2026 -- The global cell culture monitoring biosensors market is set to more than double from USD 413.8 million in 2024 to USD 906.56 million by 2032, expanding at a 10.3% compound annual growth rate, according to a new report from Credence Research Inc. Demand is being driven by biologics manufacturers, cell therapy developers and high-throughput research labs shifting away from manual sampling toward continuous, non-invasive monitoring.